Abnormal findings in specimens from other organs, systems and tissues (R89)
ICD-10 code section R89 covers abnormal findings in specimens from various organs, systems, and tissues, identifying irregularities without designating a specific diagnosis. These codes are used when laboratory tests or biopsies show unusual results that require documentation but do not yet correlate with a definitive condition.
This section includes codes like R89.0 for abnormal enzyme levels, which may involve elevated or decreased cardiac enzymes (synonymous with cardiac enzyme levels or serum aspartate aminotransferase levels outside reference range). R89.1 addresses abnormal hormone levels, covering conditions such as increased or decreased estrogen, progesterone, testosterone, or thyroid hormone levels, helping coders identify hormonal imbalances documented in test results. R89.2 and R89.3 relate to abnormal levels of drugs, medicaments, biological substances, or nonmedicinal substances like heavy metals detected in tissue samples. Codes R89.4 through R89.7 capture abnormal immunological, microbiological, cytological, and histological findings respectively, including unusual antibody detections, microbial isolates, cellular abnormalities, and biopsy results, supporting detailed recording of laboratory and pathology observations. R89.8 and R89.9 cover other and unspecified abnormal findings, such as genetic variations or unspecific abnormal biopsy outcomes. Together, these codes assist in documenting abnormal specimen results when no clear diagnosis is established, guiding accurate coding for irregular laboratory or pathology test findings.
```Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00–R99)
Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis (R83-R89)
R89 Abnormal findings in specimens from other organs, systems and tissues
- R89.0 Abnormal level of enzymes in specimens from other organs, systems and tissues
- R89.1 Abnormal level of hormones in specimens from other organs, systems and tissues
- R89.2 Abnormal level of other drugs, medicaments and biological substances in specimens from other organs, systems and tissues
- R89.3 Abnormal level of substances chiefly nonmedicinal as to source in specimens from other organs, systems and tissues
- R89.4 Abnormal immunological findings in specimens from other organs, systems and tissues
- R89.5 Abnormal microbiological findings in specimens from other organs, systems and tissues
- R89.6 Abnormal cytological findings in specimens from other organs, systems and tissues
- R89.7 Abnormal histological findings in specimens from other organs, systems and tissues
- R89.8 Other abnormal findings in specimens from other organs, systems and tissues
- R89.9 Unspecified abnormal finding in specimens from other organs, systems and tissues
Abnormal findings in specimens from other organs, systems and tissues (R89)
Instructional Notations
Includes
This note appears immediately under a three character code title to further define, or give examples of, the content of the category.
- abnormal findings in nipple discharge
- abnormal findings in synovial fluid
- abnormal findings in wound secretions
Clinical Terms
The following clinical terms provide additional context, helping users better understand the clinical background and common associations for each diagnosis listed in this section. Including related terms alongside ICD-10-CM codes supports coders, billers, and healthcare professionals in improving accuracy, enhancing documentation, and facilitating research or patient education.
Carbohydrate Conformation
The characteristic 3-dimensional shape of a carbohydrate.
Clonal Anergy
Functional inactivation of T- or B-lymphocytes rendering them incapable of eliciting an immune response to antigen. This occurs through different mechanisms in the two kinds of lymphocytes and can contribute to SELF TOLERANCE.
DNA
A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).
DNA Damage
Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS.
DNA Damage Tolerance
Strategies that cells use to continue DNA replication when replicative DNA polymerases stall at DNA damage-blocked replication forks. These DNA damage tolerant replication mechanisms bypass the DNA DAMAGE, which may be repaired subsequently by various DNA REPAIR mechanisms.
DNA End-Joining Repair
The repair of DOUBLE-STRAND DNA BREAKS by rejoining the broken ends of DNA to each other directly.
DNA Mismatch Repair
A DNA repair pathway involved in correction of errors introduced during DNA replication when an incorrect base, which cannot form hydrogen bonds with the corresponding base in the parent strand, is incorporated into the daughter strand. Excinucleases recognize the BASE PAIR MISMATCH and cause a segment of polynucleotide chain to be excised from the daughter strand, thereby removing the mismatched base. (from Oxford Dictionary of Biochemistry and Molecular Biology, 2001)
DNA Repair
The removal of DNA LESIONS and/or restoration of intact DNA strands without BASE PAIR MISMATCHES, intrastrand or interstrand crosslinks, or discontinuities in the DNA sugar-phosphate backbones.
DNA Repair Enzymes
Enzymes that are involved in the reconstruction of a continuous two-stranded DNA molecule without mismatch from a molecule, which contained damaged regions.
DNA Repair-Deficiency Disorders
Disorders resulting from defective DNA REPAIR processes or the associated cellular responses to DNA DAMAGE.
Gene Amplification
A selective increase in the number of copies of a gene coding for a specific protein without a proportional increase in other genes. It occurs naturally via the excision of a copy of the repeating sequence from the chromosome and its extrachromosomal replication in a plasmid, or via the production of an RNA transcript of the entire repeating sequence of ribosomal RNA followed by the reverse transcription of the molecule to produce an additional copy of the original DNA sequence. Laboratory techniques have been introduced for inducing disproportional replication by unequal crossing over, uptake of DNA from lysed cells, or generation of extrachromosomal sequences from rolling circle replication.
Genetic Variation
Genotypic differences observed among individuals in a population.
Molecular Conformation
The characteristic three-dimensional shape of a molecule.
MutS DNA Mismatch-Binding Protein
A methyl-directed mismatch DNA REPAIR protein that has weak ATPASE activity. MutS was originally described in ESCHERICHIA COLI.
Nucleic Acid Conformation
The spatial arrangement of the atoms of a nucleic acid or polynucleotide that results in its characteristic 3-dimensional shape.
O(6)-Methylguanine-DNA Methyltransferase
An enzyme that transfers methyl groups from O(6)-methylguanine, and other methylated moieties of DNA, to a cysteine residue in itself, thus repairing alkylated DNA in a single-step reaction. EC 2.1.1.63.
Oxidative Stress
A disturbance in the prooxidant-antioxidant balance in favor of the former, leading to potential damage. Indicators of oxidative stress include damaged DNA bases, protein oxidation products, and lipid peroxidation products (Sies, Oxidative Stress, 1991, pxv-xvi).
Point Mutation
A mutation caused by the substitution of one nucleotide for another. This results in the DNA molecule having a change in a single base pair.
Protein Conformation
The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain).
Protein Conformation, alpha-Helical
A secondary structure of proteins that is a right-handed helix or coil, where each amino (N-H) group of the peptide backbone contributes a hydrogen bond to the carbonyl(C=O) group of the amino acid four residues N-terminal to it (n-4). It is the most common type of secondary structure.
Protein Conformation, beta-Strand
A secondary structure of proteins where the amino (N-H) groups of a polypeptide backbone, three to ten amino acids in length, establish hydrogen bonds with the carbonyl (C=O) groups in the backbone of adjacent strands. These may form a beta-sheet, where the side chains of the adjacent strands point in the same direction.
Rad52 DNA Repair and Recombination Protein
A DNA-binding protein that mediates DNA REPAIR of double strand breaks, and HOMOLOGOUS RECOMBINATION.
Recombinational DNA Repair
Repair of DNA DAMAGE by exchange of DNA between matching sequences, usually between the allelic DNA (ALLELES) of sister chromatids.
Self Tolerance
The normal lack of the ability to produce an immunological response to autologous (self) antigens. A breakdown of self tolerance leads to autoimmune diseases. The ability to recognize the difference between self and non-self is the prime function of the immune system.
Transcription Factor CHOP
A CCAAT-enhancer binding protein that is induced by DNA DAMAGE and growth arrest. It serves as a dominant negative inhibitor of other CCAAT-enhancer binding proteins.